{'fraction_non_alphanumeric': 0.017105263157894738, 'fraction_numerical': 0.003947368421052632, 'mean_word_length': 5.675438596491228, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Depression and anxiety screening in North African diabetic patients: prevalence and risk factors

Since diabetes is a major public health problem worldwide, improving the quality of life of diabetic individuals has become a major therapeutic issue. Depression and anxiety screening in diabetes is beneficial in order to improve self-management, compliance to medication, dietary regimen and physical activity. Previous metaanalysis and trials suggested that treating mood disorders was associated with better glycemic control.9,10. The aim of the present study was to estimate the prevalence of anxiety and depression symptoms as assessed in Hospital Anxiety and Depression Scale (HAD) in diabetic patients hospitalized and to identify associated risk factors.